Hematologic Diseases: all 476 studies
Page 4 of 5. Open to participants first (109), then studies with results posted, then the rest; newest registration first within each.
- The Influence of Nursing Technique Applied at the Central Venous Catheter Insertion Site Upon the Incidence of InfectionCompletedNCT03875352Not applicable
- Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic DisordersCompletedNCT03855631
- Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow TransplantationActive, not recruitingNCT03842696Phase 1/2
- Multimodal Sexual Dysfunction Intervention In HCTCompletedNCT03803696Not applicable
- Oligosaccharide for Cdiff(+) Heme-onc PatientsCompletedNCT03778606Not applicable
- Fertility Preservation With Ovarian Tissue FreezingStatus unknownNCT03674164Not applicable
- A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-ThalassemiaCompletedNCT03655678Phase 2/3
- Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute AnemiaNo longer availableNCT03633604
- Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic DiseasesCompletedNCT03611257Not applicable
- Medical Clowning: Needs Assessment and Implication for Hospitalized Children With Cancer/Blood DiseaseCompletedNCT03586180
- WB-EMS and Nutrition in Patients With Hematological MalignanciesStatus unknownNCT03556748Not applicable
- Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood DopingStatus unknownNCT03548766Phase 3
- Assessment of Memory in Children With Kabuki SyndromCompletedNCT03547609Not applicable
- Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov ApproachCompletedNCT03540654
- The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients With Hematologic DiseaseStatus unknownNCT03535220
- Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood CancerCompletedNCT03488641
- Clinical Use of Pathogen Reduced Red Blood Cell SuspensionCompletedNCT03426553Phase 3
- HPA Antibodies and the Distribution of Antigen and AntibodiesCompletedNCT03408158Not applicable
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant DiseasesTerminatedNCT03367546Phase 2
- Cardiac Coherence Combined With Personal Physical Activity in Patients With CancerCompletedNCT03356171Not applicable
- Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT03343834Not applicable
- Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator TrialCompletedNCT03342495Not applicable
- French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products RecipientsCompletedNCT03313583
- Onco-coaching of Sport-inspired for the Social, Professional and Psychological Restoring of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem CellsStatus unknownNCT03272789Not applicable
- A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia MyelofibrosisActive, not recruitingNCT03165734Phase 3
- A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant RecipientsWithdrawnNCT03097796Phase 1
- Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot StudyWithdrawnNCT03086252Not applicable
- Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological DisordersCompletedNCT03079089Not applicable
- Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDSCompletedNCT03066648Phase 1
- A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological DisordersCompletedNCT03048344Phase 1
- Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical StudentsWithdrawnNCT03041571
- Multidisciplinary Follow-up of Patients Treated for Malignant Hematological DiseaseStatus unknownNCT03031106
- Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)CompletedNCT03013439Phase 1
- SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell PainCompletedNCT03006718Not applicable
- CMV-CTL for the Treatment of CMV Infection After HSCTCompletedNCT03004261Phase 4
- Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor ProductsCompletedNCT02976753
- Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromActive, not recruitingNCT02952508Phase 2
- Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma PatientsCompletedNCT02918695
- Daily Ginger Drinking and Platelet FunctionCompletedNCT02882776Not applicable
- High Resolution Donor Recipient HLA Matching Level in Unrelated HSCTCompletedNCT02827149
- Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic EngraftmentStatus unknownNCT02806791
- Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/TreatmentCompletedNCT02678910Not applicable
- Allo HSCT Using RIC for Hematological DiseasesCompletedNCT02661035Phase 2
- URMC Related Haplo-identical Donor BMTCompletedNCT02660281Phase 1
- Clinical Performance of Investigational InRhythm PT/INR System in a Professional Use SettingWithdrawnNCT02586818
- Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic DisordersCompletedNCT02484053Early Phase 1
- Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood DiseasesCompletedNCT02483325Phase 2
- Stool Transplantation to Reduce Antibiotic Resistance TransmissionStatus unknownNCT02461199
- Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology WardsStatus unknownNCT02456818
- Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic PatientsCompletedNCT02447237Not applicable
- Comparison of Educational Methods for Teaching Peripheral Blood SmearsCompletedNCT02435316Not applicable
- The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled StudyCompletedNCT02343965Not applicable
- Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute LeukemiaStatus unknownNCT02330718
- Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in PediatricsCompletedNCT02329808
- Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of ThrombocytopeniaStatus unknownNCT02241031Phase 2/3
- MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet EngraftmentStatus unknownNCT02240992Phase 2/3
- Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2TerminatedNCT02218151Not applicable
- Hematopoietic Stem Cell Transplant for High Risk HemoglobinopathiesTerminatedNCT02179359Not applicable
- Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in MyelomaWithdrawnNCT02155634Phase 3
- Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma PatientsCompletedNCT02108444
- Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem CellsCompletedNCT02090803
- MSC for Treatment of CMV InfectionStatus unknownNCT02083731Phase 2
- Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft FunctionStatus unknownNCT02083718Phase 2
- Occupational Status and Hematological DiseaseCompletedNCT02057185
- Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood DyscrasiaCompletedNCT01974401Phase 2
- Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT01959100Phase 3
- IRF-PAI Functional Outcomes Data(With FIM Instrument Variables)TerminatedNCT01779037
- Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft FailureStatus unknownNCT01763099Phase 2
- Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell TransplantStatus unknownNCT01763086Phase 2
- Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and AdolescentsCompletedNCT01737554
- Effect of the Use of Simulation (Video) on the Oral HygieneStatus unknownNCT01718002Not applicable
- Registry of Febrile Neutropenia and Invasive Fungal InfectionsStatus unknownNCT01684189
- Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKICompletedNCT01602952Phase 1/2
- Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.Status unknownNCT01579110Phase 2
- Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid SequencingTerminatedNCT01556828
- A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment OutcomesStatus unknownNCT01541631Not applicable
- The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic DiseasesTerminatedNCT01518959Phase 3
- Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase PatientsCompletedNCT01511289Phase 3
- Ultra Low Dose Interleukin-2 in Healthy VolunteersCompletedNCT01445561Phase 1
- Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the HospitalCompletedNCT01426295Phase 2
- SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)Active, not recruitingNCT01352520Phase 2
- Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological DiseasesCompletedNCT01344681Phase 2
- French Kabuki Syndrome Network. Epidemiology, Management of Patients and Research by Array-CGHCompletedNCT01314534
- Gulf Long-Term Follow-Up StudyActive, not recruitingNCT01287000
- Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological DisordersCompletedNCT01224496Phase 1/2
- Randomized Controlled Trial Comparing a Conservative Management and Laser SurgeryCompletedNCT01220011Not applicable
- Radiologic Features of Invasive Pulmonary AspergillosisCompletedNCT01178177
- Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell TransplantationStatus unknownNCT01160952Phase 2
- Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological PatientsCompletedNCT01114165Phase 4
- Integrated Whole-Genome Analysis of Hematologic DisordersCompletedNCT01108159
- Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.TerminatedNCT01066468Phase 1
- Safety of Catheter Lock With or Without Heparin in Implanted Central Venous CathetersCompletedNCT00994136Phase 4
- Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical DonorCompletedNCT00993486Phase 1/2
- Study on Systemic and Airway Biomarkers in Haemopoietic Stem Cell TransplantationCompletedNCT00956358
- Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive DebriefingCompletedNCT00909207
- Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic DisordersCompletedNCT00897260Not applicable
- Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?CompletedNCT00892502Not applicable
- Exercise During Chemotherapy for Patients With Hematological MalignanciesStatus unknownNCT00884364Phase 3
- Exercise Following Autologous Peripheral Blood Stem Cell TransplantationStatus unknownNCT00883961Phase 3
- Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell TransplantationStatus unknownNCT00856505Phase 1/2